jeudi 28 mai 2015

Teva Settles Cephalon Case With F.T.C. for $1.2 Billion Over Sleep Drug

The agency had accused the company of illegally blocking generic competition to Provigil, a sleep-disorder drug.


from NYT > Health http://ift.tt/1HPKj6E
via health&fitness

Aucun commentaire:

Enregistrer un commentaire